Sami Mahrus

机构：Diagnostics for the Real World (United States)

发表论文 60 篇 · 总被引 3406 次 · h-index 23

代表论文

Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study (2025 · The Lancet Oncology · 被引 67)
Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology Network (2025 · Journal of Hepatocellular Carcinoma · 被引 7)
Atezolizumab plus bevacizumab (A+B) in patients with unresectable hepatocellular carcinoma (uHCC): Real-world experience from a US community oncology network. (2024 · Journal of Clinical Oncology · 被引 1)
161P Real-world outcomes for unresectable hepatocellular carcinoma (uHCC) patients treated with atezolizumab plus bevacizumab (A+B) in the United States (US) (2025 · Annals of Oncology)
FRI-084 Real world treatment patterns and outcomes for hepatocellular carcinoma (HCC) patients receiving transarterial chemoembolization (TACE) or transarterial radioembolization (TARE) in the TARGET-HCC registry (2025 · Journal of Hepatology)
Supplementary Table from Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non–Small Cell Lung Cancer Trials Using Real-World Data (2023)